81 related articles for article (PubMed ID: 7936656)
1. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.
Harada H; Kondo T; Ogawa S; Tamura T; Kitagawa M; Tanaka N; Lamphier MS; Hirai H; Taniguchi T
Oncogene; 1994 Nov; 9(11):3313-20. PubMed ID: 7936656
[TBL] [Abstract][Full Text] [Related]
2. [Identification and analysis of IRF-1 binding protein].
Kondo T
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):509-16. PubMed ID: 8809574
[TBL] [Abstract][Full Text] [Related]
3. Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells.
Maratheftis CI; Bolaraki PE; Giannouli S; Kapsogeorgou EK; Moutsopoulos HM; Voulgarelis M
Leuk Res; 2006 Sep; 30(9):1177-86. PubMed ID: 16483648
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.
Giannouli S; Tzoanopoulos D; Ritis K; Kartalis G; Moutsopoulos HM; Voulgarelis M
Ann Rheum Dis; 2004 May; 63(5):578-82. PubMed ID: 15082491
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity.
Kondo T; Minamino N; Nagamura-Inoue T; Matsumoto M; Taniguchi T; Tanaka N
Oncogene; 1997 Sep; 15(11):1275-81. PubMed ID: 9315094
[TBL] [Abstract][Full Text] [Related]
6. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31).
Green WB; Slovak ML; Chen IM; Pallavicini M; Hecht JL; Willman CL
Leukemia; 1999 Dec; 13(12):1960-71. PubMed ID: 10602416
[TBL] [Abstract][Full Text] [Related]
7. Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia.
Tzoanopoulos D; Speletas M; Arvanitidis K; Veiopoulou C; Kyriaki S; Thyphronitis G; Sideras P; Kartalis G; Ritis K
Br J Haematol; 2002 Oct; 119(1):46-53. PubMed ID: 12358902
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
9. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
Tan RS; Taniguchi T; Harada H
Cancer Res; 1996 May; 56(10):2417-21. PubMed ID: 8625321
[TBL] [Abstract][Full Text] [Related]
10. Folylpoly-gamma-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues.
Leclerc GJ; Barredo JC
Clin Cancer Res; 2001 Apr; 7(4):942-51. PubMed ID: 11309345
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts.
Voulgarelis M; Giannouli S; Ritis K; Tzioufas AG
Eur J Clin Invest; 2004 Oct; 34(10):690-700. PubMed ID: 15473894
[TBL] [Abstract][Full Text] [Related]
12. Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis.
Kirchhoff S; Hauser H
Oncogene; 1999 Jun; 18(25):3725-36. PubMed ID: 10391680
[TBL] [Abstract][Full Text] [Related]
13. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.
Beretta L; Gabbay M; Berger R; Hanash SM; Sonenberg N
Oncogene; 1996 Apr; 12(7):1593-6. PubMed ID: 8622878
[TBL] [Abstract][Full Text] [Related]
14. Analysis of possible WT1 RNA processing in primary Wilms tumors.
Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
[TBL] [Abstract][Full Text] [Related]
15. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
[TBL] [Abstract][Full Text] [Related]
16. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
18. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
19. [Tissue-specific splicing of 5'-exons of the Oct-1 transcription factor gene].
Pankratova EV; Deev IE; PolianovskiÄ OL
Mol Biol (Mosk); 2001; 35(1):34-41. PubMed ID: 11234381
[TBL] [Abstract][Full Text] [Related]
20. Relation between IRF-1 gene and acute myelocytic leukemia in Kashmiri population.
Khan T; Ganai BA; Masood A; Samoon J; Beigh SR; Qazi F
Asian Pac J Cancer Prev; 2011; 12(4):1035-9. PubMed ID: 21790247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]